Aging and sex hormones in males

References

• Veldhuis JD. Changes in pituitary function with ageing and implications for patient care. Nat Rev Endocrinol 2013; 9:205-15; PMID:23438832; https://doi.org/10.1038/nrendo.2013.38
   PubMed Web of Science ®Google Scholar
• Al-Safi Z, Santoro N. The Postmenopausal Woman. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, et al., eds. Endotext. South Dartmouth MA: MDText.com, Inc., 2000.
   Google Scholar
• Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva FF, Forti G, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010; 363:123-35; PMID:20554979; https://doi.org/10.1056/NEJMoa0911101
   PubMed Web of Science ®Google Scholar
• Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metabolism 2001; 86:724-31; https://doi.org/10.1210/jcem.86.2.7219
   PubMed Web of Science ®Google Scholar
• Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005; 26:833-76; PMID:15901667; https://doi.org/10.1210/er.2004-0013
   PubMed Web of Science ®Google Scholar
• Zmuda JM, Cauley JA, Kriska A, Glynn NW, Gutai JP, Kuller LH. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol 1997; 146:609-17; PMID:9345114; https://doi.org/10.1093/oxfordjournals.aje.a009326
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Kaufman JM, Giagulli VA. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metabol 1996; 81:1821-6.
   PubMed Web of Science ®Google Scholar
• Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM, McKinlay JB. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metabol 2004; 89:5920-6; https://doi.org/10.1210/jc.2003-031719
   PubMed Web of Science ®Google Scholar
• Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 2006; 60:762-9; PMID:16846397; https://doi.org/10.1111/j.1742-1241.2006.00992.x
   PubMed Web of Science ®Google Scholar
• Schneider HJ, Sievers C, Klotsche J, Bohler S, Pittrow D, Lehnert H, Wittchen HU, Stalla GK. Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study. Clin Endocrinol 2009; 70:446-54; https://doi.org/10.1111/j.1365-2265.2008.03370.x
   PubMed Web of Science ®Google Scholar
• Handelsman DJ. Androgen Physiology, Pharmacology and Abuse. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, et al., eds. Endotext. South Dartmouth MA: MDText.com, Inc., 2000.
   Google Scholar
• Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl 2009; 30:1-9; PMID:18772485; https://doi.org/10.2164/jandrol.108.006486
   PubMedGoogle Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metabol 1999; 84:3666-72; https://doi.org/10.1210/jcem.84.10.6079
   PubMed Web of Science ®Google Scholar
• Ly LP, Sartorius G, Hull L, Leung A, Swerdloff RS, Wang C, Handelsman DJ. Accuracy of calculated free testosterone formulae in men. Clin Endocrinol 2010; 73:382-8; https://doi.org/10.1111/j.1365-2265.2010.03804.x
   PubMed Web of Science ®Google Scholar
• Travison TG, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metabol 2007; 92:549-55; https://doi.org/10.1210/jc.2006-1859
   PubMed Web of Science ®Google Scholar
• Lapauw B, Goemaere S, Zmierczak H, Van Pottelbergh I, Mahmoud A, Taes Y, De Bacquer D, Vansteelandt S, Kaufman JM. The decline of serum testosterone levels in community-dwelling men over 70 years of age: descriptive data and predictors of longitudinal changes. Eur J Endocrinol/Eur Federat Endocrine Soc 2008; 159:459-68; https://doi.org/10.1530/EJE-07-0873
   PubMed Web of Science ®Google Scholar
• Tajar A, O'Connell MD, Mitnitski AB, O'Neill TW, Searle SD, Huhtaniemi IT, Finn JD, Bartfai G, Boonen S, Casanueva FF, et al. Frailty in relation to variations in hormone levels of the hypothalamic-pituitary-testicular axis in older men: results from the European male aging study. J Am Geriatrics Soc 2011; 59:814-21; https://doi.org/10.1111/j.1532-5415.2011.03398.x
   PubMed Web of Science ®Google Scholar
• Antonio L, Wu FC, O'Neill TW, Pye SR, Carter EL, Finn JD, Rutter MK, Laurent MR, Huhtaniemi IT, Han TS, et al. Associations between sex steroids and the development of metabolic syndrome: a longitudinal study in European men. J Clin Endocrinol Metabol 2015; 100:1396-404; https://doi.org/10.1210/jc.2014-4184
   PubMed Web of Science ®Google Scholar
• Brand JS, Rovers MM, Yeap BB, Schneider HJ, Tuomainen TP, Haring R, Corona G, Onat A, Maggio M, Bouchard C, et al. Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies. PloS One 2014; 9:e100409; PMID:25019163; https://doi.org/10.1371/journal.pone.0100409
   PubMed Web of Science ®Google Scholar
• Corona G, Rastrelli G, Monami M, Saad F, Luconi M, Lucchese M, Facchiano E, Sforza A, Forti G, Mannucci E, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol/Euro Federat Endocrine Soc 2013; 168:829-43; https://doi.org/10.1530/EJE-12-0955
   PubMed Web of Science ®Google Scholar
• Palmer BF, Clegg DJ. Gonadal dysfunction in chronic kidney disease. Rev Endoc Metab Dis 2016.
   PubMed Web of Science ®Google Scholar
• Karagiannis A, Harsoulis F. Gonadal dysfunction in systemic diseases. Eur J Endocrinol/Euro Federat Endocrine Soc 2005; 152:501-13; https://doi.org/10.1530/eje.1.01886
   PubMed Web of Science ®Google Scholar
• Simoni MFF, Roli L, Pagotto U. Methodology for measuring testosterone, dihydrotestosterone and sex hormone-binding globulin in a clinical setting. In: Behre ENHM, ed. Testosterone Action, Deficiency, Substitution. Cambridge, UK: Cambridge University Press, 2012:60-86.
   Google Scholar
• Winters SJ. Laboratory Assessment of Testicular Function. In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, et al., eds. Endotext. South Dartmouth MA: MDText.com, Inc., 2000.
   Google Scholar
• Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metabol 2010; 95:2536-59; https://doi.org/10.1210/jc.2009-2354
   PubMed Web of Science ®Google Scholar
• Wang Y, Gay GD, Botelho JC, Caudill SP, Vesper HW. Total testosterone quantitative measurement in serum by LC-MS/MS. Clinica Chimica Acta; Int J Clin Chem 2014; 436:263-7; PMID:24960363; https://doi.org/10.1016/j.cca.2014.06.009
   PubMed Web of Science ®Google Scholar
• Wang C, Catlin DH, Demers LM, Starcevic B, Swerdloff RS. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metabol 2004; 89:534-43; https://doi.org/10.1210/jc.2003-031287
   PubMed Web of Science ®Google Scholar
• Fanelli F, Belluomo I, Di Lallo VD, Cuomo G, De Iasio R, Baccini M, Casadio E, Casetta B, Vicennati V, Gambineri A, et al. Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry: comparison with current immunoassays and reference intervals in healthy adults. Steroids 2011; 76:244-53; PMID:21112348; https://doi.org/10.1016/j.steroids.2010.11.005
   PubMed Web of Science ®Google Scholar
• Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metabol 2007; 92:405-13; https://doi.org/10.1210/jc.2006-1864
   PubMed Web of Science ®Google Scholar
• Rosner W, Vesper H. Toward excellence in testosterone testing: a consensus statement. J Clin Endocrinol Metabol 2010; 95:4542-8; https://doi.org/10.1210/jc.2010-1314
   PubMed Web of Science ®Google Scholar
• Ketha H, Kaur S, Grebe SK, Singh RJ. Clinical applications of LC-MS sex steroid assays: evolution of methodologies in the 21st century. Curr Opin Endocrinol, Diab Obes 2014; 21:217-26; PMID:24739314; https://doi.org/10.1097/MED.0000000000000068
   PubMed Web of Science ®Google Scholar
• Huhtaniemi IT, Tajar A, Lee DM, O'Neill TW, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A, Han TS, et al. Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. Euro J Endocrinol/ Euro Federat Endocrine Soc 2012; 166:983-91; https://doi.org/10.1530/EJE-11-1051
   PubMed Web of Science ®Google Scholar
• Morales A, Bebb RA, Manjoo P, Assimakopoulos P, Axler J, Collier C, Elliott S, Goldenberg L, Gottesman I, Grober ED, et al. Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline. CMAJ: Canadian Med Assoc J = J de l'Assoc Med Canadienne 2015; 187:1369-77; PMID:26504097; https://doi.org/10.1503/cmaj.150033
   PubMed Web of Science ®Google Scholar
• Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metabol 1983; 56:1278-81; https://doi.org/10.1210/jcem-56-6-1278
   PubMed Web of Science ®Google Scholar
• Brambilla DJ, O'Donnell AB, Matsumoto AM, McKinlay JB. Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men. Clin Endocrinol 2007; 67:853-62; PMID:18052942; https://doi.org/10.1111/j.1365-2265.2007.02976.x
   PubMed Web of Science ®Google Scholar
• Gonzalez-Sales M, Barriere O, Tremblay PO, Nekka F, Desrochers J, Tanguay M. Modeling testosterone circadian rhythm in hypogonadal males: effect of age and circannual variations. AAPS J 2016; 18:217-27; PMID:26553482; https://doi.org/10.1208/s12248-015-9841-6
   PubMed Web of Science ®Google Scholar
• Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metabol 2002; 87:589-98; https://doi.org/10.1210/jcem.87.2.8201
   PubMed Web of Science ®Google Scholar
• Huhtaniemi I. Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment. Asian J Androl 2014; 16:192-202; PMID:24407185; https://doi.org/10.4103/1008-682X.122336
   PubMed Web of Science ®Google Scholar
• Corona G, Rastrelli G, Vignozzi L, Mannucci E, Maggi M. How to recognize late-onset hypogonadism in men with sexual dysfunction. Asian J Androl 2012; 14:251-9; PMID:22286862; https://doi.org/10.1038/aja.2011.138
   PubMed Web of Science ®Google Scholar
• Corona G, Maseroli E, Rastrelli G, Francomano D, Aversa A, Hackett G, Ferri S, Sforza A, Maggi M. Is late-onset hypogonadotropic hypogonadism a specific age-dependent disease, or merely an epiphenomenon caused by accumulating disease-burden? Focusing on metabolic diseases. Minerva Endocrinol 2016; PMID:26883937
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Muller DC, Metter EJ, Maggio M, Harman SM, Blackman MR, Andres R. Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metabol 2007; 92:3568-72; https://doi.org/10.1210/jc.2006-2764
   PubMed Web of Science ®Google Scholar
• Rochira V, Kara E, Carani C. The endocrine role of estrogens on human male skeleton. Int J Endocrinol 2015; 2015:165215; PMID:25873947; https://doi.org/10.1155/2015/165215
   PubMed Web of Science ®Google Scholar
• Mellstrom D, Vandenput L, Mallmin H, Holmberg AH, Lorentzon M, Oden A, Johansson H, Orwoll ES, Labrie F, Karlsson MK, et al. Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J Bone Mineral Res: Off J Am Soc Bone Min Res 2008; 23:1552-60; PMID:18518773; https://doi.org/10.1359/jbmr.080518
   PubMed Web of Science ®Google Scholar
• Rochira V, Zirilli L, Genazzani AD, Balestrieri A, Aranda C, Fabre B, Antunez P, Diazzi C, Carani C, Maffei L. Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback. Euro J Endocrinol/ Eur Federat Endocrine Soc 2006; 155:513-22; https://doi.org/10.1530/eje.1.02254
   PubMed Web of Science ®Google Scholar
• Finkelstein JS, Lee H, Burnett-Bowie SA, Pallais JC, Yu EW, Borges LF, Jones BF, Barry CV, Wulczyn KE, Thomas BJ, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med 2013; 369:1011-22; PMID:24024838; https://doi.org/10.1056/NEJMoa1206168
   PubMed Web of Science ®Google Scholar
• Carani C, Rochira V, Faustini-Fustini M, Balestrieri A, Granata AR. Role of oestrogen in male sexual behaviour: insights from the natural model of aromatase deficiency. Clin Endocrinol 1999; 51:517-24; PMID:10583321; https://doi.org/10.1046/j.1365-2265.1999.00849.x
   PubMed Web of Science ®Google Scholar
• Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, Ellenberg SS, Matsumoto AM, Bhasin S, Molitch ME, Farrar JT, Cella D, et al. Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials. J Clin Endocrinol Metabol 2015; 100:1146-55; https://doi.org/10.1210/jc.2014-3818
   PubMed Web of Science ®Google Scholar
• Rochira V, Balestrieri A, Madeo B, Zirilli L, Granata AR, Carani C. Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology. Euro J Endocrinol / Euro Federat Endocrine Soc 2006; 154:175-85; https://doi.org/10.1530/eje.1.02088
   PubMed Web of Science ®Google Scholar
• Buvat J, Maggi M, Guay A, Torres LO. Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. J Sex Med 2013; 10:245-84; PMID:22971200; https://doi.org/10.1111/j.1743-6109.2012.02783.x
   PubMed Web of Science ®Google Scholar
• Rochira V, Guaraldi G. Hypogonadism in the HIV-infected man. Endocrinol Metab Clin North Am 2014; 43:709-30; PMID:25169563; https://doi.org/10.1016/j.ecl.2014.06.005
   PubMed Web of Science ®Google Scholar
• Rosner W, Hankinson SE, Sluss PM, Vesper HW, Wierman ME. Challenges to the measurement of estradiol: an endocrine society position statement. J Clin Endocrinol Metabol 2013; 98:1376-87; https://doi.org/10.1210/jc.2012-3780
   PubMed Web of Science ®Google Scholar
• Morley JE, Kaiser FE, Perry HM, 3rd, Patrick P, Morley PM, Stauber PM, Vellas B, Baumgartner RN, Garry PJ. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabol: Clin Exp 1997; 46:410-3; PMID:9109845; https://doi.org/10.1016/S0026-0495(97)90057-3
   PubMed Web of Science ®Google Scholar
• Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J. Clin. Endocrinol. Metabol. 1991; 73:1016-25; https://doi.org/10.1210/jcem-73-5-1016
   PubMed Web of Science ®Google Scholar
• Gray A, Berlin JA, McKinlay JB, Longcope C. An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. J Clin Epidemiol 1991; 44:671-84; PMID:1829756; https://doi.org/10.1016/0895-4356(91)90028-8
   PubMed Web of Science ®Google Scholar
• Deslypere JP, Vermeulen A. Leydig cell function in normal men: effect of age, life-style, residence, diet, and activity. J Clin Endocrinol Metabol 1984; 59:955-62; https://doi.org/10.1210/jcem-59-5-955
   PubMed Web of Science ®Google Scholar
• Baker HW, Burger HG, de Kretser DM, Hudson B, O'Connor S, Wang C, Mirovics A, Court J, Dunlop M, Rennie GC. Changes in the pituitary-testicular system with age. Clin Endocrinol 1976; 5:349-72; PMID:971543; https://doi.org/10.1111/j.1365-2265.1976.tb01964.x
   PubMed Web of Science ®Google Scholar
• Seftel AD. Male hypogonadism. Part I: epidemiology of hypogonadism. Int J Impot Res 2006; 18:115-20.
   PubMed Web of Science ®Google Scholar
• Stone JL, Norris AH. Activities and attitudes of participants in the Baltimore longitudinal study. J Gerontol 1966; 21:575-80; PMID:5918312; https://doi.org/10.1093/geronj/21.4.575
   PubMedGoogle Scholar
• Greendale GA, Edelstein S, Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Min Res: Off J Am Soc Bone Min Res 1997; 12:1833-43; PMID:9383688; https://doi.org/10.1359/jbmr.1997.12.11.1833
   PubMed Web of Science ®Google Scholar
• Bjornerem A, Straume B, Midtby M, Fonnebo V, Sundsfjord J, Svartberg J, Acharya G, Oian P, Berntsen GK. Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromso Study. J Clin Endocrinol Metabol 2004; 89:6039-47; https://doi.org/10.1210/jc.2004-0735
   PubMed Web of Science ®Google Scholar
• Mohr BA, Guay AT, O'Donnell AB, McKinlay JB. Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study. Clin Endocrinol 2005; 62:64-73; PMID:15638872; https://doi.org/10.1111/j.1365-2265.2004.02174.x
   PubMed Web of Science ®Google Scholar
• Orwoll E, Blank JB, Barrett-Connor E, Cauley J, Cummings S, Ensrud K, Lewis C, Cawthon PM, Marcus R, Marshall LM, et al. Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study–a large observational study of the determinants of fracture in older men. Contemp Clin Trials 2005; 26:569-85; PMID:16084776; https://doi.org/10.1016/j.cct.2005.05.006
   PubMed Web of Science ®Google Scholar
• Lee DM, O'Neill TW, Pye SR, Silman AJ, Finn JD, Pendleton N, Tajar A, Bartfai G, Casanueva F, Forti G, et al. The European Male Ageing Study (EMAS): design, methods and recruitment. Int J Androl 2009; 32:11-24; PMID:18328041; https://doi.org/10.1111/j.1365-2605.2008.00879.x
   PubMedGoogle Scholar
• Lee DM, Pye SR, Tajar A, O'Neill TW, Finn JD, Boonen S, Bartfai G, Casanueva FF, Forti G, Giwercman A, et al. Cohort profile: the European male ageing study. Int J Epidemiol 2013; 42:391-401; PMID:22314965; https://doi.org/10.1093/ije/dyr234
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E. The Rancho Bernardo Study: 40 years studying why women have less heart disease than men and how diabetes modifies women's usual cardiac protection. Global heart 2013; 8; PMID:24187655; https://doi.org/10.1016/j.gheart.2012.12.002
   PubMedGoogle Scholar
• Maggio M, Lauretani F, Ceda GP, Bandinelli S, Ling SM, Metter EJ, Artoni A, Carassale L, Cazzato A, Ceresini G, et al. Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study. Arch Int Med 2007; 167:2249-54; PMID:17998499; https://doi.org/10.1001/archinte.167.20.2249
   PubMed Web of Science ®Google Scholar
• Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Paolisso G, Giumelli C, Luci M, Najjar SS, Metter EJ, et al. Estradiol and metabolic syndrome in older italian men: the InCHIANTI Study. J Androl 2010; 31:155-62; PMID:19059904; https://doi.org/10.2164/jandrol.108.006098
   PubMedGoogle Scholar
• Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Ble A, Egan J, Paolisso G, Najjar S, Jeffrey Metter E, et al. Association between hormones and metabolic syndrome in older Italian men. Journal of the American Geriatrics Society 2006; 54:1832-8; PMID:17198487; https://doi.org/10.1111/j.1532-5415.2006.00963.x
   PubMed Web of Science ®Google Scholar
• Maggio M, Ceda GP, Lauretani F, Bandinelli S, Metter EJ, Guralnik JM, Basaria S, Cattabiani C, Luci M, Dall'Aglio E, et al. Gonadal status and physical performance in older men. Aging Male: Off J Int Soc Study Aging Male 2011; 14:42-7; PMID:20937007; https://doi.org/10.3109/13685538.2010.518179
   PubMed Web of Science ®Google Scholar
• Maggio M, Cattabiani C, Lauretani F, Artoni A, Bandinelli S, Schiavi G, Vignali A, Volpi R, Ceresini G, Lippi G, et al. The relationship between sex hormones, sex hormone binding globulin and peripheral artery disease in older persons. Atherosclerosis 2012; 225:469-74; PMID:23102785; https://doi.org/10.1016/j.atherosclerosis.2012.09.014
   PubMed Web of Science ®Google Scholar
• Bjornerem A, Emaus N, Berntsen GK, Joakimsen RM, Fonnebo V, Wilsgaard T, Oian P, Seeman E, Straume B. Circulating sex steroids, sex hormone-binding globulin, and longitudinal changes in forearm bone mineral density in postmenopausal women and men: the Tromso study. Calcified Tissue Int 2007; 81:65-72; PMID:17612780; https://doi.org/10.1007/s00223-007-9035-z
   PubMed Web of Science ®Google Scholar
• Bjornerem A, Ahmed LA, Joakimsen RM, Berntsen GK, Fonnebo V, Jorgensen L, Oian P, Seeman E, Straume B. A prospective study of sex steroids, sex hormone-binding globulin, and non-vertebral fractures in women and men: the Tromso Study. Euro Endocrinol / Euro Federat Endocrine Soc 2007; 157:119-25; https://doi.org/10.1530/EJE-07-0032
   PubMed Web of Science ®Google Scholar
• Cumming RG, Handelsman D, Seibel MJ, Creasey H, Sambrook P, Waite L, Naganathan V, Le Couteur D, Litchfield M. Cohort profile: the concord health and ageing in Men project (CHAMP). Int J Epidemiol 2009; 38:374-8; PMID:18480109; https://doi.org/10.1093/ije/dyn071
   PubMed Web of Science ®Google Scholar
• Hsu B, Cumming RG, Blyth FM, Naganathan V, Le Couteur DG, Seibel MJ, Waite LM, Handelsman DJ. The longitudinal relationship of sexual function and androgen status in older men: the Concord Health and Ageing in Men Project. J Clin Endocrinol Metabol 2015; 100:1350-8; https://doi.org/10.1210/jc.2014-4104
   PubMed Web of Science ®Google Scholar
• Hsu B, Cumming RG, Blyth FM, Naganathan V, Le Couteur DG, Seibel MJ, Waite LM, Handelsman DJ. Longitudinal and cross-sectional relationships of circulating reproductive hormone levels to self-rated health and health-related quality of life in community-dwelling older men. J Clin Endocrinol Metabol 2014; 99:1638-47; https://doi.org/10.1210/jc.2013-3984
   PubMed Web of Science ®Google Scholar
• Hsu B, Cumming RG, Naganathan V, Blyth FM, Le Couteur DG, Seibel MJ, Waite LM, Handelsman DJ. Associations between circulating reproductive hormones and SHBG and prevalent and incident metabolic syndrome in community-dwelling older men: the Concord Health and Ageing in Men Project. J Clin Endocrinol Metabol 2014; 99:E2686-91; https://doi.org/10.1210/jc.2014-2464
   PubMed Web of Science ®Google Scholar
• Hsu B, Cumming RG, Hirani V, Blyth FM, Naganathan V, Le Couteur DG, Seibel MJ, Waite LM, Handelsman DJ. Temporal trend in androgen status and androgen-sensitive outcomes in older Men. J Clin Endocrinol Metabol 2016; 101:1836-46; https://doi.org/10.1210/jc.2015-3810
   PubMed Web of Science ®Google Scholar
• Norman PE, Flicker L, Almeida OP, Hankey GJ, Hyde Z, Jamrozik K. Cohort profile: the health in Men study (HIMS). Int J Epidemiol 2009; 38:48-52; PMID:18316347; https://doi.org/10.1093/ije/dyn041
   PubMed Web of Science ®Google Scholar
• Fabbri E, An Y, Gonzalez-Freire M, Zoli M, Maggio M, Studenski SA, Egan JM, Chia CW, Ferrucci L. Bioavailable testosterone linearly declines over a wide age spectrum in Men and Women from the baltimore longitudinal study of aging. J Gerontol A Biol Sci Med Sci 2016.
   Web of Science ®Google Scholar
• Ferrini RL, Barrett-Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 1998; 147:750-4; PMID:9554416; https://doi.org/10.1093/oxfordjournals.aje.a009519
   PubMed Web of Science ®Google Scholar
• Hsu B, Cumming RG, Naganathan V, Blyth FM, Le Couteur DG, Hirani V, Waite LM, Seibel MJ, Handelsman DJ. Temporal changes in androgens and estrogens are associated with all-cause and cause-specific mortality in older Men. J Clin Endocrinol Metabol 2016; 101:2201-10; https://doi.org/10.1210/jc.2016-1025
   PubMed Web of Science ®Google Scholar
• Camacho EM, Huhtaniemi IT, O'Neill TW, Finn JD, Pye SR, Lee DM, Tajar A, Bartfai G, Boonen S, Casanueva FF, et al. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Euro J Endocrinol / Euro Federat Endocrine Soc 2013; 168:445-55; https://doi.org/10.1530/EJE-12-0890
   PubMed Web of Science ®Google Scholar
• Antonio L, Wu FC, O'Neill TW, Pye SR, Ahern TB, Laurent MR, Huhtaniemi IT, Lean ME, Keevil BG, Rastrelli G, et al. Low free testosterone is associated with hypogonadal signs and symptoms in Men with normal total testosterone. J Clin Endocrinol Metabol 2016:jc20154106.
   Web of Science ®Google Scholar
• Yeap BB, Almeida OP, Hyde Z, Norman PE, Chubb SA, Jamrozik K, Flicker L. In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health Men Study. Euro J Endocrinol / Euro Federat Endocrine Soc 2007; 156:585-94; https://doi.org/10.1530/EJE-06-0714
   PubMed Web of Science ®Google Scholar
• Oh JY, Barrett-Connor E, Wedick NM, Wingard DL. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diab Care 2002; 25:55-60; PMID:11772901; https://doi.org/10.2337/diacare.25.1.55
   PubMed Web of Science ®Google Scholar
• Mellstrom D, Johnell O, Ljunggren O, Eriksson AL, Lorentzon M, Mallmin H, Holmberg A, Redlund-Johnell I, Orwoll E, Ohlsson C. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Mineral Res: Off J Am Soc Bone Min Res 2006; 21:529-35; PMID:16598372; https://doi.org/10.1359/jbmr.060110
   PubMed Web of Science ®Google Scholar
• Cauley JA, Ewing SK, Taylor BC, Fink HA, Ensrud KE, Bauer DC, Barrett-Connor E, Marshall L, Orwoll ES. Sex steroid hormones in older men: longitudinal associations with 4.5-year change in hip bone mineral density–the osteoporotic fractures in men study. J Clin Endocrinol Metabol 2010; 95:4314-23; https://doi.org/10.1210/jc.2009-2635
   PubMed Web of Science ®Google Scholar
• Cawthon PM, Schousboe JT, Harrison SL, Ensrud KE, Black D, Cauley JA, Cummings SR, LeBlanc ES, Laughlin GA, Nielson CM, et al. Sex hormones, sex hormone binding globulin, and vertebral fractures in older men. Bone 2016; 84:271-8; PMID:26778261; https://doi.org/10.1016/j.bone.2016.01.009
   PubMed Web of Science ®Google Scholar
• Tajar A, Huhtaniemi IT, O'Neill TW, Finn JD, Pye SR, Lee DM, Bartfai G, Boonen S, Casanueva FF, Forti G, et al. Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J Clin Endocrinol Metabol 2012; 97:1508-16; https://doi.org/10.1210/jc.2011-2513
   PubMed Web of Science ®Google Scholar
• Tajar A, Forti G, O'Neill TW, Lee DM, Silman AJ, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metabol 2010; 95:1810-8; https://doi.org/10.1210/jc.2009-1796
   PubMed Web of Science ®Google Scholar
• Svartberg J, Midtby M, Bonaa KH, Sundsfjord J, Joakimsen RM, Jorde R. The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromso Study. Euro J Endocrinol / Euro Federat Endocrine Soc 2003; 149:145-52; https://doi.org/10.1530/eje.0.1490145
   PubMed Web of Science ®Google Scholar
• O'Connor DB, Lee DM, Corona G, Forti G, Tajar A, O'Neill TW, Pendleton N, Bartfai G, Boonen S, Casanueva FF, et al. The relationships between sex hormones and sexual function in middle-aged and older European men. J Clin Endocrinol Metabol 2011; 96:E1577-87; https://doi.org/10.1210/jc.2010-2216
   PubMed Web of Science ®Google Scholar
• Kupelian V, Shabsigh R, Travison TG, Page ST, Araujo AB, McKinlay JB. Is there a relationship between sex hormones and erectile dysfunction? Results from the Massachusetts Male Aging Study. J Urol 2006; 176:2584-8; PMID:17085164; https://doi.org/10.1016/j.juro.2006.08.020
   PubMed Web of Science ®Google Scholar
• Hall SA, Shackelton R, Rosen RC, Araujo AB. Risk factors for incident erectile dysfunction among community-dwelling men. J Sex Med 2010; 7:712-22; PMID:19929915; https://doi.org/10.1111/j.1743-6109.2009.01600.x
   PubMed Web of Science ®Google Scholar
• Pye SR, Huhtaniemi IT, Finn JD, Lee DM, O'Neill TW, Tajar A, Bartfai G, Boonen S, Casanueva FF, Forti G, et al. Late-onset hypogonadism and mortality in aging men. J Clin Endocrinol Metabol 2014; 99:1357-66; https://doi.org/10.1210/jc.2013-2052
   PubMed Web of Science ®Google Scholar
• Travison TG, Morley JE, Araujo AB, O'Donnell AB, McKinlay JB. The relationship between libido and testosterone levels in aging men. J Clin Endocrinol Metabol 2006; 91:2509-13; https://doi.org/10.1210/jc.2005-2508
   PubMed Web of Science ®Google Scholar
• LeBlanc ES, Wang PY, Janowsky JS, Neiss MB, Fink HA, Yaffe K, Marshall LM, Lapidus JA, Stefanick ML, Orwoll ES. Association between sex steroids and cognition in elderly men. Clin Endocrinol 2010; 72:393-403; PMID:19744108; https://doi.org/10.1111/j.1365-2265.2009.03692.x
   PubMed Web of Science ®Google Scholar
• Mohr BA, Bhasin S, Link CL, O'Donnell AB, McKinlay JB. The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study. Euro J Endocrinol / Euro Federat Endocrine Soc 2006; 155:443-52; https://doi.org/10.1530/eje.1.02241
   PubMed Web of Science ®Google Scholar
• Derby CA, Zilber S, Brambilla D, Morales KH, McKinlay JB. Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin Endocrinol 2006; 65:125-31; PMID:16817831; https://doi.org/10.1111/j.1365-2265.2006.02560.x
   PubMed Web of Science ®Google Scholar
• Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metabol 2008; 93:2737-45; https://doi.org/10.1210/jc.2007-1972
   PubMed Web of Science ®Google Scholar
• Vikan T, Schirmer H, Njolstad I, Svartberg J. Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. European journal of endocrinology; European Federation of Endocrine Societies 2010; 162:747-54
   Google Scholar
• Svartberg J, Jenssen T, Sundsfjord J, Jorde R. The associations of endogenous testosterone and sex hormone-binding globulin with glycosylated hemoglobin levels, in community dwelling men. Tromso Study. Diab Metab 2004; 30:29-34; https://doi.org/10.1016/S1262-3636(07)70086-1
   PubMed Web of Science ®Google Scholar
• Agledahl I, Skjaerpe PA, Hansen JB, Svartberg J. Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromso study. Nutrit Metab Cardiovasc Dis: NMCD 2008; 18:256-62; PMID:17560771; https://doi.org/10.1016/j.numecd.2007.01.014
   PubMed Web of Science ®Google Scholar
• Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J. Clin. Endocrinol. Metabol. 2006; 91:843-50; https://doi.org/10.1210/jc.2005-1326
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E. Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Annals of internal medicine 1992; 117:807-11; PMID:1416554; https://doi.org/10.7326/0003-4819-117-10-807
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Von Muhlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J. Clin. Endocrinol. Metabol. 1999; 84:573-7; https://doi.org/10.1210/jcem.84.2.5495
   PubMed Web of Science ®Google Scholar
• Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes care 2000; 23:490-4; PMID:10857940; https://doi.org/10.2337/diacare.23.4.490
   PubMed Web of Science ®Google Scholar
• Chubb SA, Hyde Z, Almeida OP, Flicker L, Norman PE, Jamrozik K, Hankey GJ, Yeap BB. Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study. Euro J Endocrinol / Euro Federat Endocrine Soc 2008; 158:785-92; https://doi.org/10.1530/EJE-07-0893
   PubMed Web of Science ®Google Scholar
• Yeap BB, Almeida OP, Hyde Z, Norman PE, Chubb SA, Jamrozik K, Hankey GJ, Flicker L. Healthier lifestyle predicts higher circulating testosterone in older men: the Health In Men Study. Clin Endocrinol 2009; 70:455-63; PMID:18691270; https://doi.org/10.1111/j.1365-2265.2008.03372.x
   PubMed Web of Science ®Google Scholar
• Svartberg J, von Muhlen D, Schirmer H, Barrett-Connor E, Sundfjord J, Jorde R. Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromso Study. Euro J Endocrinol / Euro Federat Endocrine Soc 2004; 150:65-71; https://doi.org/10.1530/eje.0.1500065
   PubMed Web of Science ®Google Scholar
• Svartberg J, von Muhlen D, Mathiesen E, Joakimsen O, Bonaa KH, Stensland-Bugge E. Low testosterone levels are associated with carotid atherosclerosis in men. J Int Med 2006; 259:576-82; PMID:16704558; https://doi.org/10.1111/j.1365-2796.2006.01637.x
   PubMed Web of Science ®Google Scholar
• Vikan T, Johnsen SH, Schirmer H, Njolstad I, Svartberg J. Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromso study. Euro J Epidemiol 2009; 24:289-95; PMID:19263227; https://doi.org/10.1007/s10654-009-9322-2
   PubMed Web of Science ®Google Scholar
• Hougaku H, Fleg JL, Najjar SS, Lakatta EG, Harman SM, Blackman MR, Metter EJ. Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements. Am J Physiol Endocrinol Metab 2006; 290:E234-42; PMID:16159908; https://doi.org/10.1152/ajpendo.00059.2005
   PubMed Web of Science ®Google Scholar
• Ohlsson C, Barrett-Connor E, Bhasin S, Orwoll E, Labrie F, Karlsson MK, Ljunggren O, Vandenput L, Mellstrom D, Tivesten A. High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am College Card 2011; 58:1674-81; https://doi.org/10.1016/j.jacc.2011.07.019
   PubMed Web of Science ®Google Scholar
• Khaw KT, Barrett-Connor E. Blood pressure and endogenous testosterone in men: an inverse relationship. J Hypertension 1988; 6:329-32; PMID:3379300; https://doi.org/10.1097/00004872-198804000-00010
   PubMed Web of Science ®Google Scholar
• Svartberg J, Jorde R. Endogenous testosterone levels and smoking in men. The fifth Tromso study. Int J Androl 2007; 30:137-43; https://doi.org/10.1111/j.1365-2605.2006.00720.x
   PubMedGoogle Scholar
• LeBlanc ES, Nielson CM, Marshall LM, Lapidus JA, Barrett-Connor E, Ensrud KE, Hoffman AR, Laughlin G, Ohlsson C, Orwoll ES. The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men. J Clin Endocrinol Metabol 2009; 94:3337-46; https://doi.org/10.1210/jc.2009-0206
   PubMed Web of Science ®Google Scholar
• Vanderschueren D, Pye SR, Venken K, Borghs H, Gaytant J, Huhtaniemi IT, Adams JE, Ward KA, Bartfai G, Casanueva FF, et al. Gonadal sex steroid status and bone health in middle-aged and elderly European men. Osteoporos Int 2010; 21:1331-9; PMID:20012940; https://doi.org/10.1007/s00198-009-1144-2
   PubMed Web of Science ®Google Scholar
• Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metabol 2008; 93:68-75; https://doi.org/10.1210/jc.2007-1792
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Laughlin GA, Li H, Nielson CM, Wang PY, Dam TT, Cauley JA, Ensrud KE, Stefanick ML, Lau E, et al. The association of concurrent vitamin D and sex hormone deficiency with bone loss and fracture risk in older men: the osteoporotic fractures in men (MrOS) study. J Bone Min Res: Off J Am Soc Bone Min Res 2012; 27:2306-13; PMID:22777902; https://doi.org/10.1002/jbmr.1697
   PubMed Web of Science ®Google Scholar
• Ward KA, Pye SR, Adams JE, Boonen S, Vanderschueren D, Borghs H, Gaytant J, Gielen E, Bartfai G, Casanueva FF, et al. Influence of age and sex steroids on bone density and geometry in middle-aged and elderly European men. Osteoporos Int 2011; 22:1513-23; PMID:21052641; https://doi.org/10.1007/s00198-010-1437-5
   PubMed Web of Science ®Google Scholar
• Hsu B, Cumming RG, Seibel MJ, Naganathan V, Blyth FM, Bleicher K, Dave A, Le Couteur DG, Waite LM, Handelsman DJ. Reproductive hormones and longitudinal change in bone mineral density and incident fracture risk in older Men: the concord health and aging in Men project. J Bone Min Res: Off J Am Soc Bone Min Res 2015; 30:1701-8; PMID:25736139; https://doi.org/10.1002/jbmr.2493
   PubMed Web of Science ®Google Scholar
• Roy TA, Blackman MR, Harman SM, Tobin JD, Schrager M, Metter EJ. Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. Am J Physiol Endocrinol Metab 2002; 283:E284-94; PMID:12110533; https://doi.org/10.1152/ajpendo.00334.2001
   PubMed Web of Science ®Google Scholar
• Hsu B, Cumming RG, Naganathan V, Blyth FM, Le Couteur DG, Seibel MJ, Waite LM, Handelsman DJ. Longitudinal relationships of circulating reproductive hormone with functional disability, muscle mass, and strength in community-dwelling older men: the Concord Health and Ageing in Men project. J Clin Endocrinol Metabol 2014; 99:3310-8; https://doi.org/10.1210/jc.2014-1124
   PubMed Web of Science ®Google Scholar
• O'Donnell AB, Travison TG, Harris SS, Tenover JL, McKinlay JB. Testosterone, dehydroepiandrosterone, and physical performance in older men: results from the Massachusetts Male Aging Study. J Clin Endocrinol Metabol 2006; 91:425-31; https://doi.org/10.1210/jc.2005-1227
   PubMed Web of Science ®Google Scholar
• LeBlanc ES, Wang PY, Lee CG, Barrett-Connor E, Cauley JA, Hoffman AR, Laughlin GA, Marshall LM, Orwoll ES. Higher testosterone levels are associated with less loss of lean body mass in older men. J Clin Endocrinol Metabol 2011; 96:3855-63; https://doi.org/10.1210/jc.2011-0312
   PubMed Web of Science ®Google Scholar
• Hyde Z, Flicker L, Almeida OP, Hankey GJ, McCaul KA, Chubb SA, Yeap BB. Low free testosterone predicts frailty in older men: the health in men study. J Clin Endocrinol Metabol 2010; 95:3165-72; https://doi.org/10.1210/jc.2009-2754
   PubMed Web of Science ®Google Scholar
• Travison TG, Nguyen AH, Naganathan V, Stanaway FF, Blyth FM, Cumming RG, Le Couteur DG, Sambrook PN, Handelsman DJ. Changes in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: the concord health and ageing in men project. J Clin Endocrinol Metabol 2011; 96:2464-74; https://doi.org/10.1210/jc.2011-0143
   PubMed Web of Science ®Google Scholar
• Cawthon PM, Ensrud KE, Laughlin GA, Cauley JA, Dam TT, Barrett-Connor E, Fink HA, Hoffman AR, Lau E, Lane NE, et al. Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metabol 2009; 94:3806-15; https://doi.org/10.1210/jc.2009-0417
   PubMed Web of Science ®Google Scholar
• Moffat SD, Zonderman AB, Metter EJ, Blackman MR, Harman SM, Resnick SM. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metabol 2002; 87:5001-7; https://doi.org/10.1210/jc.2002-020419
   PubMed Web of Science ®Google Scholar
• Zonderman AB. Predicting Alzheimer's disease in the Baltimore longitudinal study of aging. J Geriatr Psychiatry Neurol 2005; 18:192-5; PMID:16306238; https://doi.org/10.1177/0891988705281863
   PubMed Web of Science ®Google Scholar
• Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, Resnick SM. Free testosterone and risk for Alzheimer disease in older men. Neurology 2004; 62:188-93; PMID:14745052; https://doi.org/10.1212/WNL.62.2.188
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Goodman-Gruen D, Patay B. Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metabol 1999; 84:3681-5.
   PubMed Web of Science ®Google Scholar
• Yeap BB, Almeida OP, Hyde Z, Chubb SA, Hankey GJ, Jamrozik K, Flicker L. Higher serum free testosterone is associated with better cognitive function in older men, while total testosterone is not. The Health In Men Study. Clin Endocrinol 2008; 68:404-12.
   PubMed Web of Science ®Google Scholar
• Ford AH, Yeap BB, Flicker L, Hankey GJ, Chubb SA, Handelsman DJ, Golledge J, Almeida OP. Prospective longitudinal study of testosterone and incident depression in older men: the health in Men study. Psychoneuroendocrinology 2016; 64:57-65; PMID:26615472; https://doi.org/10.1016/j.psyneuen.2015.11.012
   PubMed Web of Science ®Google Scholar
• Fonda SJ, Bertrand R, O'Donnell A, Longcope C, McKinlay JB. Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study. J Gerontol A Biol Sci Med Sci 2005; 60:385-90; PMID:15860479; https://doi.org/10.1093/gerona/60.3.385
   PubMed Web of Science ®Google Scholar
• Hsu B, Cumming RG, Waite LM, Blyth FM, Naganathan V, Le Couteur DG, Seibel MJ, Handelsman DJ. Longitudinal relationships between reproductive hormones and cognitive decline in older Men: the concord health and ageing in Men project. J Clin Endocrinol Metabol 2015; 100:2223-30; https://doi.org/10.1210/jc.2015-1016
   PubMed Web of Science ®Google Scholar
• Hyde Z, Norman PE, Flicker L, Hankey GJ, Almeida OP, McCaul KA, Chubb SA, Yeap BB. Low free testosterone predicts mortality from cardiovascular disease but not other causes: the Health in Men Study. J Clin Endocrinol Metabol 2012; 97:179-89; https://doi.org/10.1210/jc.2011-1617
   PubMed Web of Science ®Google Scholar
• Araujo AB, Kupelian V, Page ST, Handelsman DJ, Bremner WJ, McKinlay JB. Sex steroids and all-cause and cause-specific mortality in men. Arch Int Med 2007; 167:1252-60; PMID:17592098; https://doi.org/10.1001/archinte.167.12.1252
   PubMed Web of Science ®Google Scholar
• Vikan T, Schirmer H, Njolstad I, Svartberg J. Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the tromso study. Euro J Endocrinol/ Euro Federat Endocrine Soc 2009; 161:435-42; https://doi.org/10.1530/EJE-09-0284
   PubMed Web of Science ®Google Scholar
• Tivesten A, Vandenput L, Labrie F, Karlsson MK, Ljunggren O, Mellstrom D, Ohlsson C. Low serum testosterone and estradiol predict mortality in elderly men. J Clin Endocrinol Metabol 2009; 94:2482-8; https://doi.org/10.1210/jc.2008-2650
   PubMed Web of Science ®Google Scholar
• Harman SM, Tsitouras PD. Reproductive hormones in aging men. I. Measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic gonadotropin. J Clin Endocrinol Metabol 1980; 51:35-40.
   PubMed Web of Science ®Google Scholar
• Burns-Cox N, Gingell C. The andropause: fact or fiction? Postgrad Med J 1997; 73:553-6; PMID:9373594; https://doi.org/10.1136/pgmj.73.863.553
   PubMed Web of Science ®Google Scholar
• Featherstone M, Hepworth M. The history of the male menopause 1848-1936. Maturitas 1985; 7:249-57; PMID:3908882; https://doi.org/10.1016/0378-5122(85)90047-7
   PubMed Web of Science ®Google Scholar
• Schultheiss D, Jonas U, Musitelli S. Some historical reflections on the ageing male. World J Urol 2002; 20:40-4; PMID:12088189; https://doi.org/10.1007/s00345-002-0254-7
   PubMed Web of Science ®Google Scholar
• Snyder PJ. Hypogonadism in elderly men–what to do until the evidence comes. N Engl J Med 2004; 350:440-2; PMID:14749451; https://doi.org/10.1056/NEJMp038207
   PubMed Web of Science ®Google Scholar
• Corona G, Rastrelli G, Maggi M. Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes. Best Pract Res Clin Endocrinol Metab 2013; 27:557-79; PMID:24054931; https://doi.org/10.1016/j.beem.2013.05.002
   PubMed Web of Science ®Google Scholar
• Petak SM, Nankin HR, Spark RF, Swerdloff RS, Rodriguez-Rigau LJ. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients–2002 update. Endocr Pract 2002; 8:440-56; PMID:15260010
   PubMedGoogle Scholar
• Nieschlag EB. H.M. Anamnesis and Physical Examination. In: Nieschlag EB,   HM, Nieschlag S, ed. Andrology. Berlin: Springer, 2010:93-100.
   Google Scholar
• Ross A, Bhasin S. Hypogonadism: its prevalence and diagnosis. Urologic Clin North America 2016; 43:163-76; PMID:27132573; https://doi.org/10.1016/j.ucl.2016.01.002
   PubMed Web of Science ®Google Scholar
• Ahern T, Swiecicka A, Eendebak RJ, Carter EL, Finn JD, Pye SR, O'Neill TW, Antonio L, Keevil B, Bartfai G, et al. Natural history, risk factors and clinical features of primary hypogonadism in ageing men: longitudinal data from the European male ageing study. Clin Endocrinol 2016; PMID:27374987
   PubMed Web of Science ®Google Scholar
• Rastrelli G, Carter EL, Ahern T, Finn JD, Antonio L, O'Neill TW, Bartfai G, Casanueva FF, Forti G, Keevil B, et al. Development of and recovery from secondary hypogonadism in aging Men: prospective results from the EMAS. J Clin Endocrinol Metabol 2015; 100:3172-82; https://doi.org/10.1210/jc.2015-1571
   PubMed Web of Science ®Google Scholar
• Kalyani RR, Gavini S, Dobs AS. Male hypogonadism in systemic disease. Endocrinol Metab Clin North Am 2007; 36:333-48; PMID:17543722; https://doi.org/10.1016/j.ecl.2007.03.014
   PubMed Web of Science ®Google Scholar
• Lunenfeld B, Mskhalaya G, Zitzmann M, Arver S, Kalinchenko S, Tishova Y, Morgentaler A. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male: Off J Int Soc Study Aging Male 2015; 18:5-15; PMID:25657080; https://doi.org/10.3109/13685538.2015.1004049
   PubMed Web of Science ®Google Scholar
• Kim S, Kwon H, Park JH, Cho B, Kim D, Oh SW, Lee CM, Choi HC. A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. BMC Gastroenterol 2012; 12:69; PMID:22691278; https://doi.org/10.1186/1471-230X-12-69
   PubMed Web of Science ®Google Scholar
• Balasubramanian V, Naing S. Hypogonadism in chronic obstructive pulmonary disease: incidence and effects. Curr Opin Pulmonary Med 2012; 18:112-7; PMID:22234275; https://doi.org/10.1097/MCP.0b013e32834feb37
   PubMed Web of Science ®Google Scholar
• Mousavi SA, Kouchari MR, Samdani-Fard SH, Gilvaee ZN, Arabi M. Relationship between serum levels of testosterone and the severity of chronic obstructive pulmonary disease. Tanaffos 2012; 11:32-5; PMID:25191426
   PubMedGoogle Scholar
• Svartberg J, Schirmer H, Medbo A, Melbye H, Aasebo U. Reduced pulmonary function is associated with lower levels of endogenous total and free testosterone. The Tromso study. Euro J Epidemiol 2007; 22:107-12; https://doi.org/10.1007/s10654-006-9095-9
   PubMed Web of Science ®Google Scholar
• Iglesias P, Carrero JJ, Diez JJ. Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options. J Nephrol 2012; 25:31-42; PMID:21748720; https://doi.org/10.5301/JN.2011.8481
   PubMed Web of Science ®Google Scholar
• Prem AR, Punekar SV, Kalpana M, Kelkar AR, Acharya VN. Male reproductive function in uraemia: efficacy of haemodialysis and renal transplantation. Brit J Urol 1996; 78:635-8; PMID:8944524; https://doi.org/10.1046/j.1464-410X.1996.14624.x
   PubMedGoogle Scholar
• Albu A, Barbu CG, Antonie L, Vladareanu F, Fica S. Risk factors associated with hypogonadism in beta-thalassemia major patients: predictors for a frequent complication of a rare disease. Postgraduate Med 2014; 126:121-7; PMID:25295656; https://doi.org/10.3810/pgm.2014.09.2806
   PubMed Web of Science ®Google Scholar
• Pelusi C, Gasparini DI, Bianchi N, Pasquali R. Endocrine dysfunction in hereditary hemochromatosis. J Endocrinol Investigat 2016; 39:837-47; PMID:26951056; https://doi.org/10.1007/s40618-016-0451-7
   PubMed Web of Science ®Google Scholar
• Luppa P, Munker R, Nagel D, Weber M, Engelhardt D. Serum androgens in intensive-care patients: correlations with clinical findings. Clin Endocrinol 1991; 34:305-10; PMID:1831739; https://doi.org/10.1111/j.1365-2265.1991.tb03771.x
   PubMed Web of Science ®Google Scholar
• Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M. Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metabol 1985; 60:444-50; https://doi.org/10.1210/jcem-60-3-444
   PubMed Web of Science ®Google Scholar
• Corona G, Rastrelli G, Maseroli E, Fralassi N, Sforza A, Forti G, Mannucci E, Maggi M. Low testosterone syndrome protects subjects with high cardiovascular risk burden from major adverse cardiovascular events. Andrology 2014; 2:741-7; PMID:25044637; https://doi.org/10.1111/j.2047-2927.2014.00241.x
   PubMed Web of Science ®Google Scholar
• Rochira V, Diazzi C, Santi D, Brigante G, Ansaloni A, Decaroli MC, De Vincentis S, Stentarelli C, Zona S, Guaraldi G. Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study. Andrology 2015; 3:298-308; PMID:25704864; https://doi.org/10.1111/andr.310
   PubMed Web of Science ®Google Scholar
• Morley JE, Melmed S. Gonadal dysfunction in systemic disorders. Metabol: Clin Exp 1979; 28:1051-73; PMID:386028; https://doi.org/10.1016/0026-0495(79)90010-6
   PubMed Web of Science ®Google Scholar
• Spratt DI, Cox P, Orav J, Moloney J, Bigos T. Reproductive axis suppression in acute illness is related to disease severity. J Clin Endocrinol Metabol 1993; 76:1548-54.
   PubMed Web of Science ®Google Scholar
• Fourrier F, Jallot A, Leclerc L, Jourdain M, Racadot A, Chagnon JL, Rime A, Chopin C. Sex steroid hormones in circulatory shock, sepsis syndrome, and septic shock. Circ Shock 1994; 43:171-8; PMID:7895322
   PubMedGoogle Scholar
• Christeff N, Benassayag C, Carli-Vielle C, Carli A, Nunez EA. Elevated oestrogen and reduced testosterone levels in the serum of male septic shock patients. J Steroid Biochem 1988; 29:435-40; PMID:3374133; https://doi.org/10.1016/0022-4731(88)90254-3
   PubMedGoogle Scholar
• Travison TG, Shackelton R, Araujo AB, Hall SA, Williams RE, Clark RV, O'Donnell AB, McKinlay JB. The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission. J Am Geriat Soc 2008; 56:831-9; PMID:18454749; https://doi.org/10.1111/j.1532-5415.2008.01679.x
   PubMed Web of Science ®Google Scholar
• Rockwood K, Mitnitski A. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriat Med 2011; 27:17-26; PMID:21093719; https://doi.org/10.1016/j.cger.2010.08.008
   PubMed Web of Science ®Google Scholar
• Mitnitski A, Collerton J, Martin-Ruiz C, Jagger C, von Zglinicki T, Rockwood K, Kirkwood TB. Age-related frailty and its association with biological markers of ageing. BMC Med 2015; 13:161; PMID:26166298; https://doi.org/10.1186/s12916-015-0400-x
   PubMed Web of Science ®Google Scholar
• Armstrong JJ, Mitnitski A, Andrew MK, Launer LJ, White LR, Rockwood K. Cumulative impact of health deficits, social vulnerabilities, and protective factors on cognitive dynamics in late life: a multistate modeling approach. Alzheimer's Res Ther 2015; 7:38; PMID:26052349; https://doi.org/10.1186/s13195-015-0120-7
   PubMed Web of Science ®Google Scholar
• Eichholzer M, Barbir A, Basaria S, Dobs AS, Feinleib M, Guallar E, Menke A, Nelson WG, Rifai N, Platz EA, et al. Serum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III). Aging Male: The Off J Int Soc Study Aging Male 2012; 15:208-15; PMID:22822787; https://doi.org/10.3109/13685538.2012.705366
   PubMed Web of Science ®Google Scholar
• Tajar A, Lee DM, Pye SR, O'Connell MD, Ravindrarajah R, Gielen E, Boonen S, Vanderschueren D, Pendleton N, Finn JD, et al. The association of frailty with serum 25-hydroxyvitamin D and parathyroid hormone levels in older European men. Age Ageing 2013; 42:352-9; PMID:23111338; https://doi.org/10.1093/ageing/afs162
   PubMed Web of Science ®Google Scholar
• Ravindrarajah R, Lee DM, Pye SR, Gielen E, Boonen S, Vanderschueren D, Pendleton N, Finn JD, Tajar A, O'Connell MD, et al. The ability of three different models of frailty to predict all-cause mortality: results from the European Male Aging Study (EMAS). Arch Gerontol Geriat 2013; 57:360-8; PMID:23871598; https://doi.org/10.1016/j.archger.2013.06.010
   PubMed Web of Science ®Google Scholar
• Vitale G, Cesari M, Mari D. Aging of the endocrine system and its potential impact on sarcopenia. Euro J Int Med 2016.
   Web of Science ®Google Scholar
• Keevil VL, Romero-Ortuno R. Ageing well: a review of sarcopenia and frailty. Proc Nutrit Soc 2015; 74:337-47; PMID:26004622; https://doi.org/10.1017/S0029665115002037
   PubMed Web of Science ®Google Scholar
• Angulo J, El Assar M, Rodriguez-Manas L. Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults. Mol Aspects Med 2016; 50:1-32; PMID:27370407; https://doi.org/10.1016/j.mam.2016.06.001
   PubMed Web of Science ®Google Scholar
• Basualto-Alarcon C, Varela D, Duran J, Maass R, Estrada M. Sarcopenia and androgens: a Link between Pathology and Treatment. Front Endocrinol 2014; 5:217; PMID:25566189
   PubMed Web of Science ®Google Scholar
• Kizilarslanoglu MC, Kuyumcu ME, Yesil Y, Halil M. Sarcopenia in critically ill patients. J Anesthesia 2016; 30:884-90; PMID:27376823; https://doi.org/10.1007/s00540-016-2211-4
   PubMed Web of Science ®Google Scholar
• Trojian TH, Lishnak TS, Heiman D. Epididymitis and orchitis: an overview. Am Fam Physician 2009; 79:583-7; PMID:19378875
   PubMed Web of Science ®Google Scholar
• El-Serafi AT, Osama S, El-Zalat H. IM EL-D. Dysregulation of male sex hormones in chronic hepatitis C patients. Andrologia 2016; 48:82-6; PMID:25912488; https://doi.org/10.1111/and.12425
   PubMed Web of Science ®Google Scholar
• Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011; 62:141-55; PMID:21090961; https://doi.org/10.1146/annurev-med-042909-093756
   PubMed Web of Science ®Google Scholar
• Rochira V, Zirilli L, Orlando G, Santi D, Brigante G, Diazzi C, Carli F, Carani C, Guaraldi G. Premature decline of serum total testosterone in HIV-infected men in the HAART-era. PloS One 2011; 6:e28512; PMID:22174826; https://doi.org/10.1371/journal.pone.0028512
   PubMed Web of Science ®Google Scholar
• Sikaris K, McLachlan RI, Kazlauskas R, de Kretser D, Holden CA, Handelsman DJ. Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays. J Clin Endocrinol Metabol 2005; 90:5928-36; https://doi.org/10.1210/jc.2005-0962
   PubMed Web of Science ®Google Scholar
• Yeap BB, Alfonso H, Chubb SA, Handelsman DJ, Hankey GJ, Norman PE, Flicker L. Reference ranges and determinants of testosterone, dihydrotestosterone, and estradiol levels measured using liquid chromatography-tandem mass spectrometry in a population-based cohort of older men. J Clin Endocrinol Metabol 2012; 97:4030-9; https://doi.org/10.1210/jc.2012-2265
   PubMed Web of Science ®Google Scholar
• Kloner RA, Carson C, 3rd Dobs A, Kopecky S, Mohler ER, 3rd. Testosterone and cardiovascular disease. J Am College Cardiol 2016; 67:545-57; PMID:26846952; https://doi.org/10.1016/j.jacc.2015.12.005
   PubMed Web of Science ®Google Scholar
• Corona G, Isidori AM, Buvat J, Aversa A, Rastrelli G, Hackett G, Rochira V, Sforza A, Lenzi A, Mannucci E, et al. Testosterone supplementation and sexual function: a meta-analysis study. J Sex Med 2014; 11:1577-92; PMID:24697970; https://doi.org/10.1111/jsm.12536
   PubMed Web of Science ®Google Scholar
• Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM, Eder R, Tennstedt S, Ulloor J, Zhang A, et al. Adverse events associated with testosterone administration. N Engl J Med 2010; 363:109-22; PMID:20592293; https://doi.org/10.1056/NEJMoa1000485
   PubMed Web of Science ®Google Scholar
• Finkle WD, Greenland S, Ridgeway GK, Adams JL, Frasco MA, Cook MB, Fraumeni JF, Jr., Hoover RN. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PloS One 2014; 9:e85805; PMID:24489673; https://doi.org/10.1371/journal.pone.0085805
   PubMed Web of Science ®Google Scholar
• Vigen R, O'Donnell CI, Baron AE, Grunwald GK, Maddox TM, Bradley SM, Barqawi A, Woning G, Wierman ME, Plomondon ME, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 2013; 310:1829-36; PMID:24193080; https://doi.org/10.1001/jama.2013.280386
   PubMed Web of Science ®Google Scholar
• Corona G, Maseroli E, Rastrelli G, Isidori AM, Sforza A, Mannucci E, Maggi M. Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis. Expert Opin Drug Saf 2014; 13:1327-51; PMID:25139126; https://doi.org/10.1517/14740338.2014.950653
   PubMed Web of Science ®Google Scholar
• Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, Bhasin S. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 2005; 60:1451-7; PMID:16339333; https://doi.org/10.1093/gerona/60.11.1451
   PubMed Web of Science ®Google Scholar
• Haddad RM, Kennedy CC, Caples SM, Tracz MJ, Bolona ER, Sideras K, Uraga MV, Erwin PJ, Montori VM. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 2007; 82:29-39; PMID:17285783; https://doi.org/10.1016/S0025-6196(11)60964-6
   PubMed Web of Science ®Google Scholar
• Fernandez-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, Agrwal N, Elamin MB, Gallegos-Orozco JF, Wang AT, et al. Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metabol 2010; 95:2560-75; https://doi.org/10.1210/jc.2009-2575
   PubMed Web of Science ®Google Scholar
• Xu L, Freeman G, Cowling BJ, Schooling CM. Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med 2013; 11:108; PMID:23597181; https://doi.org/10.1186/1741-7015-11-108
   PubMed Web of Science ®Google Scholar
• Same RV, Bell DL, Rosenthal SL, Marcell AV. Sexual and reproductive health care: adolescent and adult men's willingness to talk and preferred approach. Am J Prevent Med 2014; 47:175-81; PMID:24951042; https://doi.org/10.1016/j.amepre.2014.03.009
   PubMed Web of Science ®Google Scholar
• Hughes AK, Wittmann D. Aging sexuality: knowledge and perceptions of preparation among U.S. primary care providers. J Sex Marital Ther 2015; 41:304-13; PMID:24512220; https://doi.org/10.1080/0092623X.2014.889056
   PubMed Web of Science ®Google Scholar
• Stenholm S, Metter EJ, Roth GS, Ingram DK, Mattison JA, Taub DD, Ferrucci L. Relationship between plasma ghrelin, insulin, leptin, interleukin 6, adiponectin, testosterone and longevity in the Baltimore Longitudinal Study of Aging. Aging Clin Exp Res 2011; 23:153-8; PMID:21743292; https://doi.org/10.1007/BF03351078
   PubMed Web of Science ®Google Scholar
• Austad SN, Fischer KE. Sex Differences in Lifespan. Cell Metabol 2016; 23:1022-33; PMID:27304504; https://doi.org/10.1016/j.cmet.2016.05.019
   PubMed Web of Science ®Google Scholar
• Nieschlag E, Nieschlag S, Behre HM. Lifespan and testosterone. Nature 1993; 366:215; PMID:8232579; https://doi.org/10.1038/366215a0
   PubMed Web of Science ®Google Scholar
• Bale TL, Epperson CN. Sex differences and stress across the lifespan. Nat Neurosc. 2015; 18:1413-20; https://doi.org/10.1038/nn.4112
   PubMed Web of Science ®Google Scholar